Most Anticipated Trial Results Regarding Biomarkers in RCC

Most Anticipated Trial Results Regarding Biomarkers in RCC
Don Photo

Don
3 몇 해 431
카테고리:
묘사:
Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the anticipated trial results involving I-O, TKIs and biomarkers in renal cell carcinoma (RCC).